Frontiers Case report: Short-term eculizumab use in atypical HUS
Por um escritor misterioso
Descrição
Pregnancy associated atypical hemolytic uremic syndrome presenting with preeclampsia with HELLP syndrome and following treatment with Eculizumab
PDF) Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity
Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab
PDF) Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report
Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach.
The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab
PDF] Atypical hemolytic uremic syndrome: a syndrome in need of clarity
PDF] Pathogenesis of Atypical Hemolytic Uremic Syndrome
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
(PDF) Atypical Hemolytic Uremic Syndrome Post-Kidney Transplantation: Two Case Reports and Review of the Literature
Frontiers An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome
de
por adulto (o preço varia de acordo com o tamanho do grupo)
